The Southeast and East Asian Post-Operative Delirium (SEAPOD) Study

October 4, 2022 updated by: National University Hospital, Singapore

The specific aim of the study will be to investigate the incidences and risk factors for postoperative delirium (POD) after hip fracture surgery in elderly patients aged ≥ 65 years in five different Southeast and East Asian countries.

The secondary objectives are outlined below:

  1. To investigate factors in the hospital environments, such as noise levels, ambient lighting, nursing ratios, ward bedding and climate control, that contribute to similarities and/or differences in POD occurrences in different countries and health systems
  2. To investigate patient factors, such as disease burden, mental health, education levels, and socioeconomic factors, that contribute to similarities and/or differences in POD occurrences in different countries and health systems
  3. To quantify the direct and indirect costs, as well as resource utilization, resulting from the development of POD in each country

Study Overview

Status

Recruiting

Intervention / Treatment

Detailed Description

Hip fractures encompass all fractures of the upper (proximal) part of the thigh bone (femur). They are commonly divided into two types: intracapsular fractures, which represent those that occur within or proximal to the attachment of the hip joint capsule to the femur, and extracapsular, which represent fractures occurring below or distal to the attachment of the hip joint capsule.

Hip fractures are common in elderly people with an annual incidence rate estimated as 1.29/1000 person-years in men and 2.24/1000 person-years in women. It is the most common condition requiring physical rehabilitation in older adults. The majority (>95%) of people undergo hip surgery following hip fracture. The location of the fracture, stability, and degree of comminution (number of pieces the bone breaks into) determine which operative procedure should be used to repair the hip fracture. The aim of surgery, irrespective of the type of operation, is to reduce pain, facilitate early weight-bearing mobility to improve outcome, and facilitate independence in activities of daily living, such as bathing, dressing, and continence. However, hip fracture is associated with significant pain and loss of independence and function. Although 33-37% of patients return to their prior level of function within six months including those needing assistance, only 24% of people are independently mobile six months after hip fracture.

A major complication in elderly hip fracture patients is POD, with an incidence rate varying from 13% to 65%. POD after hip surgery was significantly associated with non-home discharge disposition, and higher odds of 30-day readmissions and 30-day mortality. POD is also associated with poor outcomes, such as lower rates of immediate postoperative weight bearing, increased pressure sores, and poorer recovery of activities of daily living. In addition, a recent meta-analysis showed that POD after hip surgery translates into long-term cognitive disease burden, by increasing the risk of incident dementia and cognitive decline by a marked odds ratio of 8.957.

No strong evidence exists regarding the treatment of delirium. Several studies performed on delirium prevention in hip fracture patients have described the use of care bundles such as orthogeriatric care and comprehensive geriatric care as an effective potential treatment for this patient group, although the evidence remains weak. However, Inouye et al stated that in the general geriatric population, 30% to 40% of the delirium episodes could be prevented by addressing modifiable risk factors.

Previous studies in the five Asian countries involved in this study show that the incidence of POD after hip fracture surgery varied greatly between countries and within countries: 12.8-27.9% in Japan, 5.07-51.3% in Korea, 13.4-45% in Thailand and 7.2% in Singapore. The incidence of POD in Malaysia can be estimated at 9-12% as reported in the recent HIP Attack trial. However, these studies were heterogenous in terms of patient selection, study methodology and hospital systems. These variations make it difficult to draw a direct comparison regarding the incidence of POD amongst Asian countries and to Western cohorts. Furthermore, the cost of POD to patients and institutions, both direct and indirect, is very poorly defined in Asian countries.

Study Type

Observational

Enrollment (Anticipated)

1000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Sendai, Japan
        • Not yet recruiting
        • Tohoku University School of Medicine
        • Contact:
          • Kotoe Kamata
      • Tokyo, Japan
        • Not yet recruiting
        • Tokyo Women's Medical University
        • Contact:
          • Yasuko Nagasaka
      • Seoul, Korea, Republic of
        • Not yet recruiting
        • Severance Hospital
        • Contact:
          • Jeong Min Kim
      • Seoul, Korea, Republic of
        • Not yet recruiting
        • St Mary's Hospital
        • Contact:
          • Hyung Mook Lee
      • Kuala Lumpur, Malaysia
        • Not yet recruiting
        • University of Malaya
        • Contact:
          • Pui San Loh
      • Malaka, Malaysia
        • Not yet recruiting
        • Universiti Sains Malaysia
        • Contact:
          • Laila Ab Mukmin
      • Singapore, Singapore, 169608
        • Not yet recruiting
        • Singapore General Hospital
        • Contact:
          • Sophia Tsong Huey Chew
      • Singapore, Singapore
        • Not yet recruiting
        • Khoo Teck Puat Hospital
        • Contact:
          • Edwin Chuen Ping Seet
      • Singapore, Singapore
        • Recruiting
        • National University Health System
      • Singapore, Singapore
        • Not yet recruiting
        • Ng Teng Fong General Hospital
        • Contact:
          • Lyn Li Lean
      • Singapore, Singapore
        • Not yet recruiting
        • Tan Tock Seng Hospital
        • Contact:
          • Vera Qinyi Lim
      • Bangkok, Thailand
        • Not yet recruiting
        • Ramathibodi Hospital
        • Contact:
          • Varinee Lekprasert
      • Bangkok, Thailand
        • Not yet recruiting
        • Siriraj Hospital
        • Contact:
          • Onuma Chaiwat

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

65 years to 100 years (Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Elderly patients aged 65 and above scheduled to undergo hip fracture surgery

Description

Inclusion Criteria:

  • Ability to provide informed consent
  • Elderly patients aged 65 years and above
  • Scheduled to undergo elective or emergency hip fracture surgery

Exclusion Criteria:

  • History of psychiatric disease
  • Baseline cognitive impairment or dementia (MOCA score < 24)
  • Illiterate (unable to read or write with local language)
  • Active history of substance abuse
  • Has a second surgery planned within 5 days of index surgery
  • Non-resident of Singapore
  • Significant hearing and/or speech impairment
  • Planned for admission into the intensive care unit after surgery

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Surgical Cohort
Elderly patients aged 65 and above who are planned for hip fracture surgery.
Battery of neurocognitive tests and questionnaires including MoCA, PHQ-9, Falls History, FIFE, STOPBANG, Nutritional Survey, Global Physical Activity Questionnaire, Brief Pain Index, NuDESC, 3D-CAM.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Development of POD in elderly patients undergoing hip fracture surgery
Time Frame: Before surgery through to 1 year post surgery
Collection of patient's demographics, medical records and surgical records to establish risk factors for POD development
Before surgery through to 1 year post surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Healthcare cost of POD in different countries and health systems
Time Frame: Before surgery through to study completion, an average of 1 year
Quantify the direct and indirect costs, as well as resource utilization, resulting from the development of POD in each country by collecting hospitalization costs
Before surgery through to study completion, an average of 1 year
Similarities and/or differences in POD occurrences in different countries and health systems
Time Frame: Before surgery through to 1 year post surgery
Collection of data such as noise levels, ambient lighting, nursing ratios, ward bedding and climate control, disease burden, mental health, education levels, and socioeconomic factors to establish similarities and/or differences in POD occurrences in different countries and health systems
Before surgery through to 1 year post surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Lian Kah Ti, National University Health System

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 22, 2021

Primary Completion (Anticipated)

December 1, 2023

Study Completion (Anticipated)

December 1, 2024

Study Registration Dates

First Submitted

June 24, 2021

First Submitted That Met QC Criteria

August 2, 2021

First Posted (Actual)

August 11, 2021

Study Record Updates

Last Update Posted (Actual)

October 6, 2022

Last Update Submitted That Met QC Criteria

October 4, 2022

Last Verified

August 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Postoperative Delirium

Clinical Trials on Neurocognitive tests

Subscribe